Presentation TCT 2025 TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention Presenter: Khaled Elnaggar October 28, 2025
Presentation TCT 2025 TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis. Presenter: Kanishk Aggarwal October 27, 2025
Presentation TCT 2025 TCT 481: Strike Early, Strike Strong—But Retest Early as Well: Two-Week LDL-C Assessment Accurately Identifies Non-Responders to Triple Oral Lipid-Lowering Therapy in ACS Patients Undergoing PCI Presenter: Kunal Mahajan October 27, 2025
Presentation TCT 2025 TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study Presenter: Kunal Mahajan October 27, 2025
Presentation TCT 2025 Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat! Presenter: Usman Baber October 26, 2025